Literature DB >> 14990357

Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress.

Gerry T M Wagenaar1, Simone A J ter Horst, Margôt A van Gastelen, Lara M Leijser, Thais Mauad, Pieter A van der Velden, Emile de Heer, Pieter S Hiemstra, Ben J H M Poorthuis, Frans J Walther.   

Abstract

Oxidative stress is an important factor in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease of premature infants characterized by arrested alveolar and vascular development of the immature lung. We investigated differential gene expression with DNA microarray analysis in premature rat lungs exposed to prolonged hyperoxia during the saccular stage of development, which closely resembles the development of the lungs of premature infants receiving neonatal intensive care. Expression profiles were largely confirmed by real-time RT-PCR (27 genes) and in line with histopathology and fibrin deposition studied by Western blotting. Oxidative stress affected a complex orchestra of genes involved in inflammation, coagulation, fibrinolysis, extracellular matrix turnover, cell cycle, signal transduction, and alveolar enlargement and explains, at least in part, the pathological alterations that occur in lungs developing BPD. Exciting findings were the magnitude of fibrin deposition; the upregulation of chemokine-induced neutrophilic chemoattractant-1 (CINC-1), monocyte chemoattractant protein-1 (MCP-1), amphiregulin, plasminogen activator inhibitor-1 (PAI-1), secretory leukocyte proteinase inhibitor (SLPI), matrix metalloproteinase-12 (MMP12), p21, metallothionein, and heme oxygenase (HO); and the downregulation of fibroblast growth factor receptor-4 (FGFR4) and vascular endothelial growth factor (VEGF) receptor-2 (Flk-1). These findings are not only of fundamental importance in the understanding of the pathophysiology of BPD, but also essential for the development of new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990357     DOI: 10.1016/j.freeradbiomed.2003.12.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  58 in total

1.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

2.  IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants.

Authors:  Joanna Floros; Douglas Londono; Derek Gordon; Patricia Silveyra; Susan L Diangelo; Rose M Viscardi; George S Worthen; Jeffrey Shenberger; Guirong Wang; Zhenwu Lin; Neal J Thomas
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

Review 3.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

4.  Fibroblast growth factor receptors control epithelial-mesenchymal interactions necessary for alveolar elastogenesis.

Authors:  Sorachai Srisuma; Soumyaroop Bhattacharya; Dawn M Simon; Siva K Solleti; Shivraj Tyagi; Barry Starcher; Thomas J Mariani
Journal:  Am J Respir Crit Care Med       Date:  2010-01-21       Impact factor: 21.405

5.  Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.

Authors:  Gerry T M Wagenaar; Rozemarijn M A Sengers; El Houari Laghmani; Xueyu Chen; Melissa P H A Lindeboom; Anton J M Roks; Gert Folkerts; Frans J Walther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-06-20       Impact factor: 5.464

Review 6.  Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia.

Authors:  Tara Sudhadevi; Alison W Ha; David L Ebenezer; Panfeng Fu; Vijay Putherickal; Viswanathan Natarajan; Anantha Harijith
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-03-10       Impact factor: 4.698

7.  Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response.

Authors:  Xueyu Chen; Frans J Walther; Rozemarijn M A Sengers; El Houari Laghmani; Asma Salam; Gert Folkerts; Tonio Pera; Gerry T M Wagenaar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-05       Impact factor: 5.464

8.  Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing.

Authors:  François Maquerlot; Stephane Galiacy; Michel Malo; Christophe Guignabert; Daniel A Lawrence; Maria-Pia d'Ortho; Georgia Barlovatz-Meimon
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  Disrupted postnatal lung development in heme oxygenase-1 deficient mice.

Authors:  Tiangang Zhuang; Monica Zhang; Huayan Zhang; Phyllis A Dennery; Qing S Lin
Journal:  Respir Res       Date:  2010-10-10

Review 10.  Manipulation of gene expression by oxygen: a primer from bedside to bench.

Authors:  Clyde J Wright; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.